bosentan anhydrous has been researched along with Vascular Diseases in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Denton, CP; Ngcozana, T; Ong, V | 1 |
| Akamata, K; Asano, Y; Ichimura, Y; Noda, S; Sato, S; Takahashi, T; Taniguchi, T; Toyama, T; Trojanowska, M; Yamashita, T | 1 |
| Pope, J; Walker, KM | 1 |
| Cardarelli, S; Cozzi, F; Favaro, M; Pigatto, E; Punzi, L; Riato, L; Rizzo, M; Zanatta, E | 1 |
4 other study(ies) available for bosentan anhydrous and Vascular Diseases
| Article | Year |
|---|---|
Management of digital vasculopathy in systemic sclerosis: benefits of multiple courses of endothelin-1 receptor antagonists.
Topics: Adult; Bosentan; Endothelin Receptor Antagonists; Female; Fingers; Humans; Scleroderma, Systemic; Skin Ulcer; Sulfonamides; Vascular Diseases | 2014 |
Endothelin receptor blockade ameliorates vascular fragility in endothelial cell-specific Fli-1-knockout mice by increasing Fli-1 DNA binding ability.
Topics: Actins; Animals; Bosentan; Capillary Permeability; Cell Line; Cells, Cultured; Chromatin Immunoprecipitation; Endothelial Cells; Endothelin Receptor Antagonists; Endothelin-1; Gene Expression; Humans; Immunoblotting; Immunohistochemistry; Mice; Mice, Knockout; Microvessels; Phosphorylation; Promoter Regions, Genetic; Protein Kinase C-delta; Proto-Oncogene Protein c-fli-1; Proto-Oncogene Proteins c-abl; Receptors, Endothelin; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Scleroderma, Systemic; Sulfonamides; Vascular Diseases | 2015 |
Expert agreement on EULAR/EUSTAR recommendations for the management of systemic sclerosis.
Topics: Bosentan; Canada; Epoprostenol; Europe; Health Surveys; Humans; Hypertension, Pulmonary; Iloprost; Methotrexate; North America; Practice Guidelines as Topic; Scleroderma, Systemic; Skin Diseases; Societies, Medical; Sulfonamides; Treatment Outcome; Vascular Diseases | 2011 |
Low occurrence of digital ulcers in scleroderma patients treated with bosentan for pulmonary arterial hypertension: a retrospective case-control study.
Topics: Aged; Antihypertensive Agents; Bosentan; Case-Control Studies; Endothelin Receptor Antagonists; Familial Primary Pulmonary Hypertension; Female; Fingers; Humans; Hypertension, Pulmonary; Male; Middle Aged; Retrospective Studies; Scleroderma, Systemic; Skin Ulcer; Sulfonamides; Time Factors; Treatment Outcome; Vascular Diseases | 2013 |